- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05897502
Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis
July 10, 2023 updated by: Liu, Liu-Yin
A 34-Week Single-Blind Trial of Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis
The purpose of this study is to assess the improvement degree of nutritional care program on the nutritional status and eating habits of hemodialysis patients
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
After being informed about the study and potential risks, all patients giving written Informed consent will undergo a 1-week screening period to determine eligibility For study entry.
At week 0, eligible patients will be assigned to the intervention group and the control group by single-blind manner(participant) with convenience sampling.
In the intervention group, the patients were trained in The Transtheoretical Model on nutritional education for 8 weeks.
In the control group, the patients were trained in roution nutrition education.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: liu-yin Liu
- Phone Number: 5121 07-6150011
- Email: ed113442@edah.org.tw
Study Contact Backup
- Name: Hsin-Lan Wen
- Phone Number: 5121 07-6150011
- Email: ed100844@edah.org.tw
Study Locations
-
-
-
Kaohsiung, Taiwan, 84402
- Recruiting
- Liu liu.yin
-
Contact:
- Liu liu.yin, postgraduate
- Phone Number: 5121 07-6150011
- Email: ed113442@edah.org.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- the biochemical value ≥ 5.5 mg/dl or albumin value<3.8g/dL
- BMI<23kg/m2
- Unexpected weight loss.
- Must be able to swallow tablets
Exclusion Criteria:
- Clinical diagnosis of Alzheimer's Disease
- Malignant tumors, gastrointestinal cachexia, and catheterization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: the theoretical model nutritional education
instruction with multimedia
|
The experimental group use multimedia education, 20 minute nutrition education courses each time, a total of 8 courses. The control group use routine education.
Other Names:
|
Placebo Comparator: control
instruction with traditional paper
|
The experimental group use multimedia education, 20 minute nutrition education courses each time, a total of 8 courses. The control group use routine education.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in Biochemical value (Albumine) at the third month
Time Frame: Baseline and the third month
|
Biochemical value (Albumine) is a validated to assess the nutritional status of hemodialysis, less than 3.8gm/dl is considered malnutrition
|
Baseline and the third month
|
Change from Baseline in Biochemical value (Albumine) at the fourth month
Time Frame: Baseline and the fourth month
|
Biochemical value (Albumine) is a validated to assess the nutritional status of hemodialysis, less than 3.8gm/dl is considered malnutrition
|
Baseline and the fourth month
|
Change from Baseline in Biochemical value (Albumine) at the sixth month
Time Frame: Baseline and the sixth month
|
Biochemical value (Albumine) is a validated to assess the nutritional status of hemodialysis, less than 3.8gm/dl is considered malnutrition
|
Baseline and the sixth month
|
Change from Baseline in Biochemical value( normalized protein catabolic rate) at the third month
Time Frame: Baseline and the third month
|
Biochemical value( normalized protein catabolic rate) is a validated to assess the nutritional status of hemodialysis, normal value greater than 1.2gm/day/k
|
Baseline and the third month
|
Change from Baseline in Biochemical value( normalized protein catabolic rate) at the fourth month
Time Frame: Baseline and the fourth month
|
Biochemical value( normalized protein catabolic rate) is a validated to assess the nutritional status of hemodialysis, normal value greater than 1.2gm/day/k
|
Baseline and the fourth month
|
Change from Baseline in Biochemical value( normalized protein catabolic rate) at the sixth month
Time Frame: Baseline and the sitxth month
|
Biochemical value( normalized protein catabolic rate) is a validated to assess the nutritional status of hemodialysis, normal value greater than 1.2gm/day/k
|
Baseline and the sitxth month
|
Change from Baseline in Biochemical value(cholesterol )at the third month
Time Frame: Baseline and the third month
|
Biochemical value( cholesterol) is a validated to assess the nutritional status of hemodialysis, less than 100mg/dl is considered malnutrition
|
Baseline and the third month
|
Change from Baseline in Biochemical value(cholesterol )at the fourth month
Time Frame: Baseline and the fourth month
|
Biochemical value( cholesterol) is a validated to assess the nutritional status of hemodialysis, less than 100mg/dl is considered malnutrition
|
Baseline and the fourth month
|
Change from Baseline in Biochemical value(cholesterol )at the sixth month
Time Frame: Baseline and and the sixth month
|
Biochemical value( cholesterol) is a validated to assess the nutritional status of hemodialysis, less than 100mg/dl is considered malnutrition
|
Baseline and and the sixth month
|
Change from Baseline in Biochemical value(creatine)at the third month
Time Frame: Baseline and the third month
|
Biochemical value(creatine) is a validated to assess the nutritional status of hemodialysis, less than 8-10 mg/dl before hemodialysis indicates malnutrition
|
Baseline and the third month
|
Change from Baseline in Biochemical value(creatine) at the fourth month
Time Frame: Baseline and the fourth month
|
Biochemical value(creatine) is a validated to assess the nutritional status of hemodialysis, less than 8-10 mg/dl before hemodialysis indicates malnutrition
|
Baseline and the fourth month
|
Change from Baseline in Biochemical value(creatine) at the sixth month
Time Frame: Baseline and the sixth month
|
Biochemical value(creatine) is a validated to assess the nutritional status of hemodialysis, less than 8-10 mg/dl before hemodialysis indicates malnutrition
|
Baseline and the sixth month
|
Change from Baseline in Biochemical value( Phosphate) at the third month
Time Frame: Baseline and the third month
|
Biochemical value(Phosphate) is a validated to assess the nutritional status of hemodialysis, normal value is 2.7-4.5 mg/dL
|
Baseline and the third month
|
Change from Baseline in Biochemical value( Phosphate) at the fourth month
Time Frame: Baseline and the fourth month
|
Biochemical value(Phosphate) is a validated to assess the nutritional status of hemodialysis, normal value is 2.7-4.5 mg/dL
|
Baseline and the fourth month
|
Change from Baseline in Biochemical value( Phosphate) at the sixth month
Time Frame: Baseline and the sixth month
|
Biochemical value(Phosphate) is a validated to assess the nutritional status of hemodialysis, normal value is 2.7-4.5 mg/dL
|
Baseline and the sixth month
|
Change from Baseline in body measurement ( Hand grip strength ) at the third month
Time Frame: Baseline and the third month
|
Hand grip strength is a validated to assess the nutritional status of hemodialysis, male ≤ 30 kilograms, female ≤ 20 kilograms, indicating a risk of frailty
|
Baseline and the third month
|
Change from Baseline in body measurement ( Hand grip strength ) at the fourth month
Time Frame: Baseline and the fourth month
|
Hand grip strength is a validated to assess the nutritional status of hemodialysis, male ≤ 30 kilograms, female ≤ 20 kilograms, indicating a risk of frailty
|
Baseline and the fourth month
|
Change from Baseline in body measurement ( Hand grip strength ) at the sixth month
Time Frame: Baseline and the sixth month
|
Hand grip strength is a validated to assess the nutritional status of hemodialysis, male ≤ 30 kilograms, female ≤ 20 kilograms, indicating a risk of frailty
|
Baseline and the sixth month
|
Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF) at the third month
Time Frame: Baseline and the third month
|
(Mini Nutritional Assessment-Short Form, MNA-SF) is a validated self-reported instrument to assess the nutritional status of hemodialysis,Out of 14 points.
≤11 points malnutrition risk.
≤7 points malnutrition.
|
Baseline and the third month
|
Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF) at the fourth month
Time Frame: Baseline and the fourth month
|
(Mini Nutritional Assessment-Short Form, MNA-SF) is a validated self-reported instrument to assess the nutritional status of hemodialysis,Out of 14 points.
≤11 points malnutrition risk.
≤7 points malnutrition.
|
Baseline and the fourth month
|
Change from Baseline in (Mini Nutritional Assessment-Short Form, MNA-SF) at the sixth month
Time Frame: Baseline and the six month
|
(Mini Nutritional Assessment-Short Form, MNA-SF) is a validated self-reported instrument to assess the nutritional status of hemodialysis,Out of 14 points.
≤11 points malnutrition risk.
≤7 points malnutrition.
|
Baseline and the six month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in the diet of knowledge form at the third month
Time Frame: Baseline and the third month
|
The diet of knowledge form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 10 points.
The higher the score, the positive performance on healthy diet knowledge
|
Baseline and the third month
|
Change from Baseline in the diet of knowledge form at the fourth month
Time Frame: Baseline and the fourth month
|
The diet of knowledge form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 10 points.
The higher the score, the positive performance on healthy diet knowledge
|
Baseline and the fourth month
|
Change from Baseline in the diet of knowledge form at the sixth month
Time Frame: Baseline and the sixth month
|
The diet of knowledge form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 10 points.
The higher the score, the positive performance on healthy diet knowledge
|
Baseline and the sixth month
|
Change from Baseline in the diet of attitude form at the third month
Time Frame: Baseline and the third month
|
The diet of attitude form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points.
A higher score indicates a positive attitude towards healthy eating
|
Baseline and the third month
|
Change from Baseline in the diet of attitude form at the fourth month
Time Frame: Baseline and the fourth month
|
The diet of attitude form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points.
A higher score indicates a positive attitude towards healthy eating
|
Baseline and the fourth month
|
Change from Baseline in the diet of attitude form at the sixth month
Time Frame: Baseline and the sixth month
|
The diet of attitude form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points.
A higher score indicates a positive attitude towards healthy eating
|
Baseline and the sixth month
|
Change from Baseline in the diet of behavior form at the third month
Time Frame: Baseline and the third month
|
The diet of behavior form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points.
A higher score indicates a positive performance on healthy eating behavior
|
Baseline and the third month
|
Change from Baseline in the diet of behavior form at the fourth month
Time Frame: Baseline and the fourth month
|
The diet of behavior form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points.
A higher score indicates a positive performance on healthy eating behavior
|
Baseline and the fourth month
|
Change from Baseline in the diet of behavior form at the sixth month
Time Frame: Baseline and the sixth month
|
The diet of behavior form is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 20 points.
A higher score indicates a positive performance on healthy eating behavior
|
Baseline and the sixth month
|
Change from Baseline in the high phosphorus food frequency questionnaire at the third month
Time Frame: Baseline and the third month
|
The high phosphorus food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 42.
The higher the score, the negative the frequency of food intake with high phosphorus.
|
Baseline and the third month
|
Change from Baseline in the high phosphorus food frequency questionnaire at the fourth month
Time Frame: Baseline and the fourth month
|
The high phosphorus food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 42.
The higher the score, the negative the frequency of food intake with high phosphorus.
|
Baseline and the fourth month
|
Change from Baseline in the high phosphorus food frequency questionnaire at the sixth month
Time Frame: Baseline and the sixth month
|
The high phosphorus food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,The full score is 42.
The higher the score, the negative the frequency of food intake with high phosphorus.
|
Baseline and the sixth month
|
Change from Baseline in the six major food frequency questionnaire at the third month
Time Frame: Baseline and the third month
|
The six major food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,Full score is 12 points.
A higher score indicates a balanced performance on the six major food intake frequencies
|
Baseline and the third month
|
Change from Baseline in the six major food frequency questionnaire at the fourth month
Time Frame: Baseline and the fourth month
|
The six major food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,Full score is 12 points.
A higher score indicates a balanced performance on the six major food intake frequencies
|
Baseline and the fourth month
|
Change from Baseline in the six major food frequency questionnaire at the sixth month
Time Frame: Baseline and the sixth month
|
The six major food frequency questionnaire is a validated self-reported instrument to assess the eating habits of hemodialysis patients,Full score is 12 points.
A higher score indicates a balanced performance on the six major food intake frequencies
|
Baseline and the sixth month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: liu-yin Liu, The Nursing department of EDAHospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 6, 2023
Primary Completion (Actual)
July 11, 2023
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
May 18, 2023
First Submitted That Met QC Criteria
June 7, 2023
First Posted (Actual)
June 9, 2023
Study Record Updates
Last Update Posted (Actual)
July 11, 2023
Last Update Submitted That Met QC Criteria
July 10, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Metabolic Diseases
- Urologic Diseases
- Disease Attributes
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Phosphorus Metabolism Disorders
- Chronic Disease
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Kidney Diseases
- Kidney Failure, Chronic
- Hyperphosphatemia
Other Study ID Numbers
- EMRP-112-047
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Based on the privacy and confidentiality factors of the subjects' personal data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End-Stage Kidney Disease
-
Bioconnect Systems, IncCompletedEnd-stage Renal Disease | End-stage Kidney DiseaseUnited States
-
University of MichiganTheravance BiopharmaCompletedEnd-Stage Renal Disease | Stage 5 Chronic Kidney DiseaseUnited States
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedEnd-stage Kidney DiseaseUnited States
-
Ewha Womans UniversityUnknownEnd-Stage Kidney Disease
-
University of ChicagoCompletedEnd-Stage Kidney DiseaseUnited States
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
Sahlgrenska University Hospital, SwedenNot yet recruiting
-
Duke-NUS Graduate Medical SchoolNational University Hospital, Singapore; Singapore General HospitalRecruitingEnd-Stage Kidney DiseaseSingapore
-
University of WashingtonCompleted
-
AbbottTerminatedEnd-Stage Kidney DiseaseUnited States
Clinical Trials on multimedia education
-
Chang Gung Memorial HospitalCompletedQuality of Life | Enterostomy | Self-care | Multimedia Learning EducationTaiwan
-
Akdeniz UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedAnxiety | Abnormal Uterine BleedingTurkey
-
Hepatopancreatobiliary Surgery Institute of Gansu...CompletedHealth EducationChina
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedType 2 Diabetes Mellitus | Insulin | Education
-
Nomi Waqas GulIndus Hospital and Health NetworkCompletedChemotherapy EffectPakistan
-
University of ChicagoCompletedParental Language BehaviorsUnited States
-
Royal College of Surgeons, IrelandEIDO HealthcareCompleted
-
Saint Francis CareAmerican Cancer Society, Inc.; Northwestern University Feinberg School of MedicineCompletedColorectal CancerUnited States
-
University of SheffieldEthicon Endo-Surgery; HCA International Limited; DigimedCompletedFocus of Study: Cognitive Surgical Skill AcquisitionUnited Kingdom